99
Views
1
CrossRef citations to date
0
Altmetric
Research Articles

Use of cellulose acetate butyrate as a carrier for preparation of alcohol-resistant matrix tablet

ORCID Icon, &
Pages 729-734 | Received 16 Oct 2019, Accepted 02 Mar 2020, Published online: 16 Mar 2020

References

  • Ali R. 2017. Ammonio methacrylate copolymer as a carrier for water-insoluble drug, preparation and characterization of an oral controlled-release matrix tablet. J Drug Deliv Sci Technol. 41:7–12.
  • Ali R, Walther M, Bodmeier R. 2018. Cellulose acetate butyrate: ammonio methacrylate copolymer blends as a novel coating in osmotic tablets. AAPS Pharm Sci Tech. 19:148–154.
  • Balamurali V, Pramodkuma TM, Srujana N, Venkatesh MP, Gupta NV, Krishna KL, Gangadhara HV. 2011. pH sensitive drug delivery systems: a review. Am J Drug Discov Dev. 1:24–48.
  • Barra J, Falson-Rieg F, Doelker E. 2000. Modified drug release from inert matrix tablets prepared from formulations of identical composition but different organisations. J Control Release. 65:419–428.
  • Colombo P, Bettini R, Santi P, Peppas NA. 2000. Swellable matrices for controlled drug delivery: gel-layer behaviour, mechanisms and optimal performance. Pharm Sci Technol Today. 3:198–204.
  • Dabbagh MA, Ford JL, Rubinstein MH, Hogan JE. 1996. Effects of polymer particle size, compaction pressure and hydrophilic polymers on drug release from matrices containing ethylcellulose. Int J Pharm. 140:85–95.
  • Eastman. 2006. Cellulose acetate butyrate (CAB-553-0.4) product data sheet. http://www.eastman.com/Products/Pages/ProductHome.aspx?Product=71001222
  • Friebe TP, Gray A, Asgarzadeh F, Hughes K, Hebestreit JP, Rosiaux Y, Yunis M, Faham A. 2015. Regulatory considerations for alcohol-induced dose dumping of oral modified-release formulations. Pharm Technol. 38:20–26.
  • Frömming KH, Schwabe L. 1980. In vivo drug release from microencapsulated acetylsalicylic acid with simultaneous alcohol uptake. Arzneimittelforschung. 30:836–839.
  • Frömming KH, Topaloglu Y. 1975. Beeinflussung der In-vitro- und In-vivo-Pharmakonfreisetzung aus einigen peroralen Depotformen unter Athanolbelastung. Arzneimittel-Forschung. 25:1958–1964.
  • Garekani HA, Ford JL, Rubinstein MH, Rajabi-Siahboomi AR. 2001. Effect of compression force, compression speed, and particle size on the compression properties of paracetamol. Drug Dev. Ind. Pharm. 27:935–942.
  • Grund J, Koerber M, Walther M, Bodmeier R. 2014. The effect of polymer properties on direct compression and drug release from water-insoluble controlled release matrix tablets. Int J Pharm. 469:94–101.
  • Hamed R, AlJanabi R, Sunoqrot S, Abbas A. 2017. The effect of pH, buffer capacity and ionic strength on quetiapine fumarate release from matrix tablets prepared using two different polymeric blends. Drug Dev Ind Pharm. 43:1330–1342.
  • Hodsdon AC, Mitchell JR, Davies MC, Melia CD. 1995. Structure and behaviour in hydrophilic matrix sustained release dosage forms: 3. The influence of pH on the sustained-release performance and internal gel structure of sodium alginate matrices. J Control Release. 33:143–152.
  • Katikaneni PR, Upadrashta SM, Neau SH, Mitra AK. 1995. Ethylcellulose matrix controlled release tablets of a water-soluble drug. Int J Pharm. 123:119–125.
  • Korsmeyer RW, Gurny R, Doelker E, Buri P, Peppas NA. 1983. Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm. 15:25–35.
  • Lindahl A, Ungell A, Knutson L, Lennernäs H. 1997. Characterization of fluids from the stomach and proximal jejunum in men and women. Pharm Res. 14:497–502.
  • Meyer R, Hussain A. 2005. Awareness topic: mitigating the risks of ethanol induced dose dumping from oral sustained/controlled release dosage forms. Proceedings of the FDA’s ACPS Meeting. 1–4.
  • Polli JE, Rekhi GS, Augsburger LL, Shah VP. 1997. Methods to compare dissolution profiles and a rationale for wide dissolution specifications for metoprolol tartrate tablets. J Pharm Sci. 86:690–700.
  • Ritger PL, Peppas NA. 1987. A simple equation for description of solute release I. Fickian and non-fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs. J Control Release. 5:23–36.
  • Shameem M, Katori LN, Aoyagi N, Kojima S. 1995. Oral solid controlled release dosage forms: role of GI-mechanical destructive forces and colonic release in drug absorption under fasted and fed conditions in humans. Pharm Res. 12:1049–1054.
  • Song SH, Chae BR, Sohn SI, Yeom DW, Son HY, Kim JH, Kim SR, Lee SG, Choi YW. 2016. Formulation of controlled-release pelubiprofen tablet using Kollidon® SR. Int J Pharm. 511:864–875.
  • Varum FJO, Hatton GB, Basit AW. 2013. Food, physiology and drug delivery. Int J Pharm. 457:446–460.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.